You just read:

Synthetic Biologics to Discuss Phase II Results of Oral Estriol Candidate Trimesta™ for Relapsing-Remitting Multiple Sclerosis in Women

News provided by

Synthetic Biologics, Inc.

Apr 30, 2014, 06:58 ET